[Federal Register Volume 89, Number 93 (Monday, May 13, 2024)]
[Notices]
[Pages 41440-41441]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-10300]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Advisory Council for the Elimination of 
Tuberculosis

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Advisory Council for the Elimination of 
Tuberculosis (ACET). This meeting is open to the public, limited only 
by the number of audio and web conference lines (1,000 lines are 
available). Time will be available for public comment (registration is 
required to provide oral comment).

DATES: The meeting will be held on June 25, 2024, from 9:30 a.m. to 
4:30 p.m., EDT, and June 26, 2024, from 10 a.m. to 12 p.m., EDT.
    Written comments must be submitted by July 2, 2024. Registration to 
make oral comments must be submitted by June 18, 2024.

ADDRESSES: The telephone access number is 1-669-254-5252, Webinar ID: 
160 567 2365, and the Passcode is 53696016. The web conference access 
is https://cdc.zoomgov.com/j/1605672365?pwd=Vjd0N0JIdjR3ZTZUZ21kaTcvMHVTZz09, and the Passcode is 
9?A=EB8b. The number of available audio and web conference lines is 
1,000.

FOR FURTHER INFORMATION CONTACT: Marah Condit, M.S., Committee 
Management Lead, Office of Policy, Planning, and Partnerships, National 
Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for 
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6, 
Atlanta, Georgia 30329-4027. Telephone: (404) 639-3423; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Council for the Elimination of Tuberculosis 
is charged with providing advice and recommendations regarding the 
elimination of tuberculosis (TB) to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, Centers 
for Disease Control and Prevention (CDC). Specifically, the Council 
makes recommendations regarding policies, strategies, objectives, and 
priorities; addresses the development and application of new 
technologies; provides guidance and review on CDC's Tuberculosis 
Prevention Research portfolio and program priorities; and reviews the 
extent to which progress has been made toward eliminating TB.
    Matters to be Considered: The agenda will include discussions on: 
(1) CDC's National Center for HIV, Viral Hepatitis, STD, and TB 
Prevention Update; (2) CDC's Division of Tuberculosis Elimination 
Update; (3) TB in New Arrivals; (4) Regulation of Laboratory Developed 
Tests and the Impact on TB Testing in the United States; (5) National 
Tuberculosis Coalition of America Guidelines for Respiratory Isolation 
and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in 
Community Settings; (6)

[[Page 41441]]

Laboratory Developed Tests Workgroup Update; and (7) Drug Shortage 
Workgroup Update. Agenda items are subject to change as priorities 
dictate.

Public Participation

    Written Public Comment: Members of the public are welcome to submit 
written comments in advance of the meeting. Written comments must be 
submitted by emailing [email protected] with subject line ``ACET 
June 2024 Public Comment Registration'' by July 2, 2024.
    Oral Public Comment: Individuals who would like to make an oral 
comment during the public comment period must register by emailing 
[email protected] with subject line ``ACET June 2024 Public Comment 
Registration'' by June 18, 2024. The public comment period is on June 
26, 2024, at 10:15 a.m., EDT.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-10300 Filed 5-10-24; 8:45 am]
BILLING CODE 4163-18-P